Search research articles
Contact Us
Filters
Showing results (21-30 of 109) with videos related to
Page
of 11
Sort By:
Current Opinion in Oncology
|
May 3, 2013
Diagnosis, prognosis, and management of leiomyosarcoma: recognition of anatomic variants
Andrew J Bathan, Anastasia Constantinidou, Seth M Pollack, et al.
American Journal of Clinical Oncology
|
July 14, 2009
Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: a clinical review
Seth M Pollack, Thomas P O'Connor, Jana Hashash, et al.
Current Treatment Options in Oncology
|
November 15, 2022
Combinations of Chemotherapy and PD-1/PD-L1 Inhibitors in Sarcoma
Meghan M Lynch, Borislav A Alexiev, Brett A Schroeder, et al.
Marine Drugs
|
February 17, 2015
Trabectedin in soft tissue sarcomas
Bradley J Petek, Elizabeth T Loggers, Seth M Pollack, et al.
Journal of Experimental Pharmacology
|
September 21, 2018
Propranolol for the treatment of vascular sarcomas
Michael J Wagner, Lee D Cranmer, Elizabeth T Loggers, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
April 30, 2013
The use of radiofrequency ablation in gastrointestinal stromal tumor
Seth M Pollack, Venu G Pillarisetty, Siddharth A Padia, et al.
Current Treatment Options in Oncology
|
March 24, 2017
Phase III Soft Tissue Sarcoma Trials: Success or Failure?
Alexander T J Lee, Seth M Pollack, Paul Huang, et al.
Ebiomedicine
|
May 24, 2016
Drug repositioning in sarcomas and other rare tumors
Alex T J Lee, Paul H Huang, Seth M Pollack, et al.
Oncotargets and Therapy
|
June 11, 2016
Targeting gastrointestinal stromal tumors: the role of regorafenib
Brett Schroeder, Zula Li, Lee D Cranmer, et al.
Cancer Management and Research
|
February 15, 2018
Advances in the treatment of soft tissue sarcoma: focus on eribulin
Panagiotis Koliou, Vasilios Karavasilis, Maria Theochari, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 109) with videos related to
Sort By:
Page
of 11
Current Opinion in Oncology
|
May 3, 2013
Diagnosis, prognosis, and management of leiomyosarcoma: recognition of anatomic variants
Andrew J Bathan, Anastasia Constantinidou, Seth M Pollack, et al.
American Journal of Clinical Oncology
|
July 14, 2009
Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: a clinical review
Seth M Pollack, Thomas P O'Connor, Jana Hashash, et al.
Current Treatment Options in Oncology
|
November 15, 2022
Combinations of Chemotherapy and PD-1/PD-L1 Inhibitors in Sarcoma
Meghan M Lynch, Borislav A Alexiev, Brett A Schroeder, et al.
Marine Drugs
|
February 17, 2015
Trabectedin in soft tissue sarcomas
Bradley J Petek, Elizabeth T Loggers, Seth M Pollack, et al.
Journal of Experimental Pharmacology
|
September 21, 2018
Propranolol for the treatment of vascular sarcomas
Michael J Wagner, Lee D Cranmer, Elizabeth T Loggers, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
April 30, 2013
The use of radiofrequency ablation in gastrointestinal stromal tumor
Seth M Pollack, Venu G Pillarisetty, Siddharth A Padia, et al.
Current Treatment Options in Oncology
|
March 24, 2017
Phase III Soft Tissue Sarcoma Trials: Success or Failure?
Alexander T J Lee, Seth M Pollack, Paul Huang, et al.
Ebiomedicine
|
May 24, 2016
Drug repositioning in sarcomas and other rare tumors
Alex T J Lee, Paul H Huang, Seth M Pollack, et al.
Oncotargets and Therapy
|
June 11, 2016
Targeting gastrointestinal stromal tumors: the role of regorafenib
Brett Schroeder, Zula Li, Lee D Cranmer, et al.
Cancer Management and Research
|
February 15, 2018
Advances in the treatment of soft tissue sarcoma: focus on eribulin
Panagiotis Koliou, Vasilios Karavasilis, Maria Theochari, et al.
Page
of 11